Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials ...
clinicaltrialsarena41 分钟
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
GlobalData is the parent company of Clinical Trials Arena. Amgen and AstraZeneca are also investigating Tezspire in other ...